Showing results (1-10 of 10) with videos related to
Sort By:
Pageof 1
SLAS Technology|January 21, 2022
Lab-made 3D printed stoppers as high-throughput cell migration screening toolSilvina Acosta, Lucía Canclini, Carlos Galarraga, et al.Journal of Proteomics|June 11, 2026
Violacein as a multitarget agent in bladder cancer cellsJuan F Idiarte, Lucía Canclini, Diego Alem, et al.World Journal of Microbiology & Biotechnology|July 19, 2020
Production and antiproliferative effect of violacein, a purple pigment produced by an Antarctic bacterial isolateDiego Alem, Juan José Marizcurrena, Verónica Saravia, et al.Environmental Toxicology and Pharmacology|March 29, 2019
Chemosensitizer effect of cisplatin-treated bladder cancer cells by phenazine-5,10-dioxidesPaola Hernández, Diego Alem, Marcos Nieves, et al.Biomedicines|January 21, 2023
New Nitric Oxide-Releasing Compounds as Promising Anti-Bladder Cancer DrugsMaría Varela, Miriam López, Mariana Ingold, et al.Journal of Medicinal Chemistry|December 2, 2022
Development of SOS1 Inhibitor-Based Degraders to Target <i>KRAS</i>-Mutant Colorectal CancerYujia Bian, Diego Alem, Francisca Beato, et al.Scientific Reports|February 5, 2025
Amyloids in bladder cancer hijack cancer-related proteins and are positive correlated to tumor stageDiego Alem, César X García-Laviña, Francisco Garagorry, et al.Molecular Carcinogenesis|April 12, 2023
Translational relevance of SOS1 targeting for KRAS-mutant colorectal cancerDiego Alem, Xinrui Yang, Francisca Beato, et al.Scientific Reports|March 16, 2022
Neuroprotective effects of violacein in a model of inherited amyotrophic lateral sclerosisSilvia Olivera-Bravo, Carmen Bolatto, Gabriel Otero Damianovich, et al.International Journal of Radiation Biology|May 29, 2024
LBDNet interlaboratory comparison for the dicentric chromosome assay by digitized image analysis applying weighted robust statistical methodsJorge Ernesto González Mesa, Diego Alem Glison, Fabio Andrés Chaves-Campos, et al.Pageof 1